Sesen Bio announced positive preliminary data from its ongoing Phase 3 VISTA trial, a single-arm, multi-center clinical trial designed to support the ...
AVEO Pharmaceuticals, Pipeline Review and Potential Catalysts
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is a biopharmaceutical company, develops and commercializes a portfolio of targeted medicines for oncology a...
Will Your Insurance Pay for a ReWalk Robotics Solution for Paralysis? FDA Clearance
Update 06/10/19- ReWalk Robotics stock soars after receiving FDA clearance for its exosuit- https://finance.yahoo.com/video/rewalk-robotics-stock-soar...
Jaguar Health Pipeline Review, Progress and Regulatory Update
JAGX announced that Mytesi® (crofelemer) has been added to the formulary for Florida's AIDS Drug Assistance Program (ADAP).
Stem Cell Collaboration Results Push Cellect Biotechnology Shares Higher, Full Analysis
Cellect Biotechnology Ltd. (NASDAQ: APOP) is a biotechnology company, focused on developing technologies for the functional selection of stem cells in...
Novavax Shares Gain as its Lead Compounds Move Forward, Analysts Review and Target
Novavax (NASDAQ: NVAX) is up a mind blowing 6300% following our coverage in 2018 here!
ARCA Biopharma, European Patent for Gencaro and Q3 Review
ARCA Biopharma (NASDAQ: ABIO) and Medtronic have entered into a collaboration to support GENETIC-AF, ARCA’s clinical trial evaluating Gencaro as a tre...